UNSPSC 51111783: Brentuximab vedotin

Brentuximab vedotin is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL).

UNSPSC 51111783 Brentuximab vedotin is a Commodity code, but the recent state and local opportunities tagged under it do not reflect pharmaceutical procurement aligned with this oncology drug's scope. Of the eight opportunities in the dataset, only two address pharmaceutical services directly: Dane County's RFP for comprehensive pharmacy services at a long-term care facility and West Texas Centers' RFP for prescription and pharmacy services across mental health and developmental disability service sites. The remaining six opportunities involve unrelated services—EMS drug-dosage calculation software (Collier County), a naloxone distribution center letter of interest (Washington County, Oregon), forensic drug reference standards (Pinellas County), public aquatic center operations, a Group Purchasing Organization contract, and BLS/ALS pharmaceuticals and vending machines for emergency response (Tucson Fire Department). The code shows minimal recent activity aligned with its nominal scope as a branded pharmaceutical product.

The two pharmaceutical-services opportunities that do appear span different operational contexts and issuing bodies. Dane County is seeking proposals for pharmacy services at Badger Prairie Health Care Center, a county-owned long-term care facility, with an RFP due October 22, 2026, emphasizing daily medication delivery, barcode scanning, electronic dispensing integration, and five-year contract performance; the county currently funds these services at $125,000 annually and applies a local-vendor preference (5 bonus points for Dane County vendors, 2 for adjacent counties). West Texas Centers for Mental Health and Mental Retardation issued an RFP for prescription and pharmacy services across over 7,000 individuals at 35 service sites in 23 counties, due August 21, 2026, requiring 48-hour standard order turnaround, Clozaril National Registry participation, and integration with Streamline EHR; compensation uses tiered markup structures plus per-prescription and per-patient fees. Activity is limited to Wisconsin and Texas; the code does not support a clear signal of active procurement interest in brentuximab vedotin or comparable specialty pharmaceuticals at the state and local level.